Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Case Reports in Oncology|December 24, 2021
Therapy of Angiosarcoma with Thalidomide and LenalidomideM Jules Mattes, Jeffrey A Mattes, Roman Groisberg, et al.
Molecular Cancer Therapeutics|June 16, 2005
In vitro cytotoxicity of carcinoma cells with 111In-labeled antibodies to HER-2Rosana B Michel, Philip M Andrews, Mary Ellen Castillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
In vitro toxicity of A-431 carcinoma cells with antibodies to epidermal growth factor receptor and epithelial glycoprotein-1 conjugated to radionuclides emitting low-energy electronsRosana B Michel, Mary Ellen Castillo, Philip M Andrews, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 5, 2009
Induction of apoptosis by cross-linking antibodies bound to human B-lymphoma cells: expression of Annexin V binding sites on the antibody capM Jules Mattes, Rosana B Michel, David M Goldenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab)M Jules Mattes, Robert M Sharkey, Habibe Karacay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Therapy of small subcutaneous B-lymphoma xenografts with antibodies conjugated to radionuclides emitting low-energy electronsRosana B Michel, Adriane V Rosario, Philip M Andrews, et al.
Nuclear Medicine and Biology|April 12, 2005
177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivoRosana B Michel, Philip M Andrews, Adriane V Rosario, et al.
Nuclear Medicine and Biology|June 29, 2005
Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugatesSerengulam V Govindan, Rosana B Michel, Gary L Griffiths, et al.
Nuclear Medicine and Biology|September 23, 2003
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74Rosana B Michel, Adriane V Rosario, Martin W Brechbiel, et al.
Cancer Biotherapy & Radiopharmaceuticals|July 26, 2002
Use of galactosylated-streptavidin as a clearing agent with 111In-labeled, biotinylated antibodies to enhance tumor/non-tumor localization ratiosSerengulam V Govindan, Gary L Griffiths, Rosana B Michel, et al.
Pageof 3